Daniel J. De Klerk

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Journal: Biochemical pharmacology

Published: September 13, 2025

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Pharmacological targeting of nuclear factor (erythroid-derived 2)-like 2 (NRF2): a potential strategy to improve the efficacy of oncological photodynamic therapy.

Journal: Biochemical pharmacology

Published: September 13, 2025

Comparative analysis of whole cell-derived vesicular delivery systems for photodynamic therapy of extrahepatic cholangiocarcinoma.

Comparative analysis of whole cell-derived vesicular delivery systems for photodynamic therapy of extrahepatic cholangiocarcinoma.

Journal: Journal of photochemistry and photobiology. B, Biology

Published: January 09, 2024

Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 03, 2022

Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.

Strategies for Improving Photodynamic Therapy Through Pharmacological Modulation of the Immediate Early Stress Response.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: May 03, 2022

Metallated phthalocyanines and their hydrophilic derivatives for multi-targeted oncological photodynamic therapy.

Metallated phthalocyanines and their hydrophilic derivatives for multi-targeted oncological photodynamic therapy.

Journal: Journal of photochemistry and photobiology. B, Biology

Published: March 10, 2022

Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.

Attritional evaluation of lipophilic and hydrophilic metallated phthalocyanines for oncological photodynamic therapy.

Journal: Journal of photochemistry and photobiology. B, Biology

Published: October 31, 2020

DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.

DNA methyltransferases expression in normal tissues and various human cancer cell lines, xenografts and tumors.

Journal: Nucleosides, nucleotides & nucleic acids

Published: January 22, 2019

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance.

Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance.

Journal: Cancers

Published: November 08, 2018

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne.

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne.

Journal: Scientific reports

Published: October 10, 2017

The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2.

The Cytidine Analog Fluorocyclopentenylcytosine (RX-3117) Is Activated by Uridine-Cytidine Kinase 2.

Journal: PloS one

Published: March 04, 2016

Showing 1-11 of 11

Last Updated: 09/26/2026